Alvin J. Cummins, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
In the past 3 years experimental therapy on 12 patients with chronic active hepatitis has been carried out in the Clinical Research Center of the University of Tennessee. The drugs used in therapy have been either azathioprine (Imuran®) or 6-mercaptopurine. There are suggestive data indicating that chronic active hepatitis may, in part at least, be pathogenetically related to an autoimmune reaction. In such cases immunosuppressive drugs could be clinically beneficial.
Of the 12 patients, 4 could not be continued on therapy beyond a minimal period of 30 days due to complications of the illness or of therapy. The remaining eight
Cummins AJ. Treatment of Chronic Active Hepatitis with Immunosuppressive Drugs.. Ann Intern Med. ;70:1066. doi: 10.7326/0003-4819-70-5-1066_2
Download citation file:
Published: Ann Intern Med. 1969;70(5):1066.
Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use